The therapeutic challenge of Gram-negative sepsis: Prolonging the lifespan of a scarce resource

Clinical Microbiology and Infection, Supplement

Volumn 11, Issue 6, 2005, Pages 18-22

  Richards, G A ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Medical School   (South Africa)

Author keywords

Antibiotic management; Resistance; Selection pressure

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DROTRECOGIN; ERTAPENEM; IMIPENEM; INSULIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; STEROID; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; AWARENESS; BACTERIAL TRANSMISSION; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM DETECTION; CAPILLARY LEAK SYNDROME; CYTOKINE PRODUCTION; DEVICE INFECTION; DISINFECTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SENSITIVITY; DRUG USE; DRUG UTILIZATION; EDUCATION; ERYTHROCYTE TRANSFUSION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; INTESTINE VILLUS ATROPHY; LENGTH OF STAY; LEUKOCYTE ADHERENCE; LONG TERM CARE; MICROANGIOPATHY; MORTALITY; MULTIDRUG RESISTANCE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PERSONNEL MANAGEMENT; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RESUSCITATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SHORT COURSE THERAPY; STAFF TRAINING; SUPERINFECTION; SURVIVAL; TREATMENT FAILURE; TREATMENT WITHDRAWAL; VASODILATATION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 27544492891     PISSN: 14709465     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01266.x     Document Type: Review

References (50)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50.
2. Driedman G, Silva E, Vincent J-L. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26: 2078-86.
3. Martin GS, Mannino D, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
4. Bacl IC, Sungurtekin H, Gurses E et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7: 85-90.
5. Dellinger RP, Corle JM, Masur H, Gerlach H, eds. The surviving sepsis campaign guidelines for the management of severe sepsis and septic shock: background recommendations and discussion from an evidence-based review. Crit Care Med 2004; 32(suppl).
6. Trouillet JL, Chastre J, Vuagnat A et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531-539.
7. Rello J, Torres A, Ricart M et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150(6 Part 1): 1545-1549.
8. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108(6): 1655-1662.
9. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31: S131-S138.
10. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
11. Leone M, Bourgoin A, Cambon S et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003; 31: 462-467.
12. Namias N, Samiian L, Nino D et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 2000; 49: 638-645.
13. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A et al. Impact on the outcome of adequate empirical antibiotherapy in patients admitted to the ICU for sepsis. Crit Care Med 2003; 31: 2742-2751.
14. Ibrahim EH, Ward S, Sherman G et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29(6): 1109-1115.
15. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-474.
16. Singh N, Rogers P, Atwood CW et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162(2 Part 1): 505-511.
17. Gruson D, Hilbert G, Vargas F et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic resistant gram-negative bacteria. Am J Respir Crit Care Med 2000; 162: 837-843.
18. Ibrahim EH, Ward S, Sherman G et al. Experience with a clinical guideline for the treatment of ventilator associated pneumonia. Crit Care Med 2001; 29: 1109-1115.
19. Dean CR, Visalli MA, Projan SJ et al. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 2003; 47(3): 972-978.
20. Paterson DL. 'Collateral damage' from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004; 38(suppl 4): S341-S345.
21. Chamot E, El Amari EB, Rohner P. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteraemia. Antimicrob Agents Chemother 2003; 47: 2756-2764.
22. Paul M, Benuri-Silbiger I, Soares-Weiser K, Liebovici L. β-Lactam monotherapy versus β-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and metaanalysis of randomised trials. BMJ 2004; 328: 668-688.
23. Dennesen PJW, van der Ven AJ, Kessels AGH et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator associated pneumonia. Am J Respir Crit Care Med 2001; 163: 1371-1375.
24. Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
25. Hoffken G, Niederman M. Nosocomial pneumonia. The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122: 2183-2196.
26. Rello J, Vidaur L, Sandiumenge A et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32: 2183-2190.
27. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125: 1791-1799.
28. Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233-1237.
29. Du B, Chen D, Liu D et al. Restriction of third-generation cephalosporin use decreases infection-related mortality. Crit Care Med 2003; 31: 1088-1093.
30. Gruson D, Hilbert G, Vargas F et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003; 31: 1908-1914.
31. Warren DK, Hill HA, Merz MR. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial resistant gram negative bacteria among intensive care unit patients. Crit Care Med 2004; 32: 2450-2456.
32. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
33. Berenholtz SM, Pronovost PJ, Lipsett P et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32: 2014-2020.
34. Tablan OC, Anderson LJ, Besser R et al. Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53(RR-3): 1-36.
35. Drakulovic MB, Torres A, Bauer TT et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354: 1851-1858.
36. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leukocyte depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-845.
37. Hebert PC, Wells G, Blajchman MA et al. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
38. Rubinson L, Diette GB, Song X et al. Low caloric intake is associated with bloodstream infections in the medical intensive care unit. Crit Care Med 2004; 32: 350-357.
39. Girou E, Loyeau S, Legrand P et al. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial. BMJ 2002; 325: 362-365.
40. Hugonnet S, Perneger TV, Pittet D. Alcohol-based handrub improves compliance with hand hygiene in intensive care units. Arch Intern Med 2002; 13(162): 1037-1043.
41. Rello J, Lorente C, Bodí M et al. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. Chest 2002; 122: 656-661.
42. Ricart M, Lorente C, Diaz E et al. Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. Crit Care Med 2003; 31: 2693-2696.
43. Babcock H, Zack J, Garrison T et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004; 125: 2224-2231.
44. Pronovost PJ, Angus DC, Dorman T et al. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA 2002; 288: 2151-2162.
45. Pronovost PJ, Jenckes MW, Dorman T et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999; 281(14): 1310-1317.
46. Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital. Infection Control Program. Ann Intern Med 1999; 19(130): 126-130.
47. Needleman J, Buerhaus P, Mattke S et al. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 2002; 30(346): 1715-1722.
48. Robert J, Fridkin SK, Blumberg HM et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000; 21(1): 12-17.
49. Pronovost P, Needham D, Waters H et al. Intensive care unit physician staffing: financial modeling of the Leapfrog standard. Crit Care Med 2004; 32: 1247-1253.
50. Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2004; 2: 73-78.